WallStSmart

CareTrust REIT Inc. (CTRE)vsDiversified Healthcare Trust (DHC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Diversified Healthcare Trust generates 190% more annual revenue ($1.52B vs $522.55M). CTRE leads profitability with a 64.1% profit margin vs -21.1%. CTRE appears more attractively valued with a PEG of 1.26. CTRE earns a higher WallStSmart Score of 60/100 (C).

CTRE

Buy

60

out of 100

Grade: C

Growth: 6.7Profit: 8.0Value: 6.0Quality: 7.0
Piotroski: 3/9Altman Z: 2.46

DHC

Hold

39

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 6.3Quality: 5.5
Piotroski: 5/9Altman Z: -0.24
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CTREUndervalued (+14.4%)

Margin of Safety

+14.4%

Fair Value

$46.03

Current Price

$37.97

$8.06 discount

UndervaluedFair: $46.03Overvalued
DHCUndervalued (+89.5%)

Margin of Safety

+89.5%

Fair Value

$60.18

Current Price

$8.53

$51.65 discount

UndervaluedFair: $60.18Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTRE4 strengths · Avg: 9.3/10
Profit MarginProfitability
64.1%10/10

Keeps 64 of every $100 in revenue as profit

Operating MarginProfitability
57.8%10/10

Strong operational efficiency at 57.8%

Debt/EquityHealth
0.229/10

Conservative balance sheet, low leverage

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

DHC1 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Areas to Watch

CTRE2 concerns · Avg: 3.5/10
Revenue GrowthGrowth
3.2%4/10

3.2% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

DHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.894/10

Expensive relative to growth rate

Debt/EquityHealth
1.493/10

Elevated debt levels

Return on EquityProfitability
-19.8%2/10

ROE of -19.8% — below average capital efficiency

Revenue GrowthGrowth
-5.3%2/10

Revenue declined 5.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : CTRE

The strongest argument for CTRE centers on Profit Margin, Operating Margin, Debt/Equity. Profitability is solid with margins at 64.1% and operating margin at 57.8%. PEG of 1.26 suggests the stock is reasonably priced for its growth.

Bull Case : DHC

The strongest argument for DHC centers on Price/Book.

Bear Case : CTRE

The primary concerns for CTRE are Revenue Growth, Piotroski F-Score.

Bear Case : DHC

The primary concerns for DHC are PEG Ratio, Debt/Equity, Return on Equity.

Key Dynamics to Monitor

CTRE profiles as a value stock while DHC is a turnaround play — different risk/reward profiles.

DHC carries more volatility with a beta of 2.32 — expect wider price swings.

CTRE is growing revenue faster at 3.2% — sustainability is the question.

CTRE generates stronger free cash flow (87M), providing more financial flexibility.

Bottom Line

CTRE scores higher overall (60/100 vs 39/100), backed by strong 64.1% margins. DHC offers better value entry with a 89.5% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CareTrust REIT Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

CareTrust REIT, Inc. is a publicly traded, self-managed real estate investment trust engaged in the ownership, acquisition, development, and leasing of skilled nursing, senior housing, and other healthcare-related properties.

Visit Website →

Diversified Healthcare Trust

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

DHC is a real estate investment trust, or REIT, that owns medical offices and life science properties, senior communities and wellness centers throughout the United States. The company is headquartered in Newton, MA.

Visit Website →

Want to dig deeper into these stocks?